These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2564379)

  • 41. Low responder T cell susceptibility to the suppressive function of regulatory T cells in patients with dilated cardiomyopathy.
    Tang H; Zhong Y; Zhu Y; Zhao F; Cui X; Wang Z
    Heart; 2010 May; 96(10):765-71. PubMed ID: 20448127
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cellular immune response to myelin basic proteins in patients with dilated cardiomyopathy].
    Aleksandrova LZ; Bakhov NI; Titov VN; Gervazieva VB; Naumov VG
    Ter Arkh; 1987; 59(12):51-7. PubMed ID: 2451862
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Dilated cardiomyopathy--a chronic myocarditis? Immunohistological characterization of lymphocytic infiltrates].
    Kühl U; Daun B; Seeberg B; Schultheiss HP; Strauer BE
    Herz; 1992 Apr; 17(2):97-106. PubMed ID: 1577368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
    Castelli G; Fornaro A; Ciaccheri M; Dolara A; Troiani V; Tomberli B; Olivotto I; Gensini GF
    Circ Heart Fail; 2013 Sep; 6(5):913-21. PubMed ID: 23888044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy.
    Avci A; Alizade E; Fidan S; Yesin M; Guler Y; Kargin R; Esen AM
    Scand Cardiovasc J; 2014 Aug; 48(4):202-8. PubMed ID: 24912526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation.
    Parodi O; De Maria R; Oltrona L; Testa R; Sambuceti G; Roghi A; Merli M; Belingheri L; Accinni R; Spinelli F
    Circulation; 1993 Aug; 88(2):509-22. PubMed ID: 8339413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictors of natural killer cell-mediated cytotoxicity deficiency in advanced heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
    Doering LV; Vredevoe DL; Woo MA; Fonarow GC; Skotsko C; Bonavida B
    Am J Cardiol; 1997 Jul; 80(2):234-6. PubMed ID: 9230174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy.
    Kühl U; Seeberg B; Schultheiss HP; Strauer BE
    Eur Heart J; 1994 Aug; 15 Suppl C():62-7. PubMed ID: 7995272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression profiling from endomyocardial biopsy tissue allows distinction between subentities of dilated cardiomyopathy.
    Ruppert V; Meyer T; Pankuweit S; Möller E; Funck RC; Grimm W; Maisch B;
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):360-369.e1. PubMed ID: 18692642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocyte subsets in patients with dilated cardiomyopathy and perimyocarditis.
    Takamoto T; Hori Y; Yokoyama MM; Koga Y; Toshima H
    J Clin Lab Immunol; 1986 Mar; 19(3):113-6. PubMed ID: 3754903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
    Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
    Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum interleukin-6 in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Roig E; Orús J; Paré C; Azqueta M; Filella X; Perez-Villa F; Heras M; Sanz G
    Am J Cardiol; 1998 Sep; 82(5):688-90, A8. PubMed ID: 9732906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy.
    Blyszczuk P; Kania G; Dieterle T; Marty RR; Valaperti A; Berthonneche C; Pedrazzini T; Berger CT; Dirnhofer S; Matter CM; Penninger JM; Lüscher TF; Eriksson U
    Circ Res; 2009 Oct; 105(9):912-20. PubMed ID: 19762681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of lymphocyte subsets in patients with aplastic anaemia.
    Zoumbos NC; Ferris WO; Hsu SM; Goodman S; Griffith P; Sharrow SO; Humphries RK; Nienhuis AW; Young N
    Br J Haematol; 1984 Sep; 58(1):95-105. PubMed ID: 6235836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frequency, prognosis and predictors of improvement of systolic left ventricular function in patients with 'classical' clinical diagnosis of idiopathic dilated cardiomyopathy.
    Cicoira M; Zanolla L; Latina L; Rossi A; Golia G; Brighetti G; Zardini P
    Eur J Heart Fail; 2001 Jun; 3(3):323-30. PubMed ID: 11378003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies.
    Limas CJ; Goldenberg IF; Limas C
    Circulation; 1995 Feb; 91(3):631-4. PubMed ID: 7828286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
    Bulut D; Creutzenberg G; Mügge A
    Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.